Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
| Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
| Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
| SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
| iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
| Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
| Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
| Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape
03/20 07:00 am
GlobeNewswire Inc.
Read morePfizer vs Moderna: Which Pharma Stock Has More Upside?
03/19 03:30 pm
The Motley Fool
Read moreUnnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
03/16 07:00 am
GlobeNewswire Inc.
Read moreZostavax Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/09 10:59 am
GlobeNewswire Inc.
Read moreRotateq Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/09 10:54 am
GlobeNewswire Inc.
Read more1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid
03/08 01:30 pm
The Motley Fool
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreAI-Powered Tempus Inks New Multi-Year Merck Deal
03/03 03:33 pm
Benzinga
Read moreMXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems
03/03 05:53 am
GlobeNewswire Inc.
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read more3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade
02/28 05:37 am
The Motley Fool
Read moreA Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
02/27 03:52 pm
GlobeNewswire Inc.
Read more1 Reason I'd Buy Veeva Systems Stock and Never Sell
02/23 05:37 pm
The Motley Fool
Read moreMerck's Strategic Shift Signals New Growth Horizons
02/23 10:16 am
Benzinga
Read moreMerck Discloses Positive Data For Respiratory Syncytial Virus Antibody Treatment, Seeks FDA Nod For Broader Child Use
02/19 08:56 am
Benzinga
Read moreMerck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery
02/18 02:05 pm
Benzinga
Read moreFDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer
02/18 11:10 am
Benzinga
Read more2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
02/14 09:15 am
The Motley Fool
Read moreDid Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
02/13 11:15 am
The Motley Fool
Read more2 Undervalued Blue Chip Stocks to Buy as the Dow Tops 50,000 Milestone
02/11 03:35 pm
Investing.com
Read moreMerck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients
02/11 11:26 am
Benzinga
Read moreHepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally
02/11 05:00 am
GlobeNewswire Inc.
Read moreShould You Buy Moderna Before Feb. 13?
02/10 12:15 am
The Motley Fool
Read moreStock Market Today, Feb. 9: Oracle Climbs on AI Optimism Despite Software Sector Weakness
02/09 06:02 pm
The Motley Fool
Read more3 Top Dow Jones Dividend Stocks to Buy for Passive Income in 2026
02/08 10:25 am
The Motley Fool
Read moreImmutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
02/06 09:00 am
GlobeNewswire Inc.
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
02/05 04:57 am
GlobeNewswire Inc.
Read moreMerck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow
02/03 12:06 pm
Benzinga
Read moreChromatography Research Report 2026 - Global $13.69 Bn Market Trends, Opportunities, and Forecasts to 2031
01/30 05:59 am
GlobeNewswire Inc.
Read moreFDA Accepts Summit's Lung Cancer Drug Application, Review Underway
01/29 01:28 pm
Benzinga
Read more2 Pharmaceutical Stocks Set to Rebound in 2026
01/27 11:17 am
The Motley Fool
Read moreWhy Revolution Medicines Stock Plummeted by Almost 17% Today
01/26 08:16 pm
The Motley Fool
Read moreWhy Is Cancer Drug Developer Erasca Stock Trading Lower Monday?
01/26 08:52 am
Benzinga
Read moreRevolution Medicines Stock Sinks After Merck Deal Talks Collapse
01/26 07:01 am
Benzinga
Read more1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income
01/24 08:30 pm
The Motley Fool
Read more2 Dirt Cheap Stocks to Buy With $200 Right Now
01/24 10:01 am
The Motley Fool
Read moreLipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies
01/23 11:00 am
GlobeNewswire Inc.
Read moreJanux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million
01/22 03:02 pm
Benzinga
Read moreFDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer
01/22 01:51 pm
Benzinga
Read morePostpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
01/22 12:00 pm
GlobeNewswire Inc.
Read moreStock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)
01/22 09:46 am
Benzinga
Read moreModerna Stock Rallies as Oncology Results Improve the Platform’s Value Case
01/21 03:38 pm
Investing.com
Read moreHigh Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
01/21 12:00 pm
GlobeNewswire Inc.
Read moreJohnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative
01/21 10:43 am
Investing.com
Read moreModerna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
01/20 05:21 pm
Benzinga
Read moreSun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
01/20 11:31 am
Benzinga
Read more